Overview of microbicides for the prevention of human immunodeficiency virus
- 2 March 2012
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 26 (4), 427-439
- https://doi.org/10.1016/j.bpobgyn.2012.01.010
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Epidemiological Impact of Tenofovir Gel on the HIV Epidemic in South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in womenThe Lancet, 2011
- Prevention of vaginal SHIV transmission in macaques by a live recombinant LactobacillusMucosal Immunology, 2011
- Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in womenAIDS, 2011
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenNew England Journal of Medicine, 2010
- PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trialThe Lancet, 2010
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in WomenScience, 2010
- Heterosexual anal intercourse among community and clinical settings in Cape Town, South AfricaSexually Transmitted Infections, 2009
- Critical issues in mucosal immunity for HIV-1 vaccine developmentJournal of Allergy and Clinical Immunology, 2008
- Anal and dry sex in commercial sex work, and relation to risk for sexually transmitted infections and HIV in Meru, KenyaSexually Transmitted Infections, 2006